Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA

    International journal of chronic obstructive pulmonary disease, Volume 13, 2018, Pages 2969-2984.

    Cited by: 1|Bibtex|Views27|Links
    WOS
    Keywords:
    COPDbronchodilatorco-suspension delivery technologymuscarinic antagonistβ2-agonist

    Abstract:

    These results demonstrated the efficacy of GFF MDI in patients with moderate-to-very severe COPD. GFF MDI was well tolerated, with a safety profile commensurate with long-acting bronchodilators.

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments